Formal policies and special informed consent are associated with higher provider utilization of CDC high-risk donor organs

American Journal of Transplantation

Volumn 9, Issue 3, 2009, Pages 629-635

  Kucirka, L M ^a   Namuyinga, R ^a   Hanrahan, C ^a   Montgomery, R A ^a   Segev, D L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Deceased donor transplantation; High risk donor; HIV; Informed consent

Indexed keywords

ARTICLE; CADAVER DONOR; CLINICAL PRACTICE; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HUMAN; INFECTION RISK; INFORMED CONSENT; KIDNEY TRANSPLANTATION; NORMAL HUMAN; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; SURGEON;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); HEALTH CARE SURVEYS; HUMANS; INFORMED CONSENT; RISK ASSESSMENT; RISK FACTORS; TISSUE DONORS; TRANSPLANTATION; TRANSPLANTS; UNITED STATES;

EID: 60649098391     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02523.x     Document Type: Article

References (19)

1. Singer AL, Kucirka LM, Namuyinga RHC, Subramanian AK, Segev DL. The high risk donor: Viral infections in solid organ transplantation. Curr Opin Organ Transplant 2008 13 : 400 404.
2. UNOS. Communication of donor history. 2008. Available from : http://www.unos.org/SharedContentDocuments/2008JuneBOD- CombinedPolicyNoticeFINAL.pdf. Accessed September 12, 2008.
3. Provisional Public Health Service inter-agency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome. 1985. Available from : http://www.cdc.gov/mmwr/ preview/mmwrhtml/00033029.htm. Accessed September 12, 2008.
4. Rogers, MF, Lawton KE, Moseley RR, Jones WK. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. 1994. Available from : http://www.cdc.gov/MMWR/preview/ mmwrhtml/00031670.htm Accessed May 2, 2008.
5. Minimum procurement standards for an organ procurement organization. 2008. Available from : http://www.unos.org/PoliciesandBylaws2/policies/pdfs/ policy-2.pdf. Accessed September 12, 2008.
6. Biswas R, Tabor E, Hsia CC et al. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003 43 : 788 798.
7. Busch MP. HIV, HBV and HCV: New developments related to transfusion safety. Vox Sang 2000 78 (Suppl 2 253 256.
8. Busch MP. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors Transfus Clin Biol 2004 11 : 26 32.
9. Busch MP, Glynn SA, Stramer SL et al. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005 45 : 254 264.
10. Busch MP, Lee LL, Satten GA et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: Implications for screening of blood and tissue donors. Transfusion 1995 35 : 91 97.
11. Fishman JA, Greenwald MA, Kuehnert MJ. Enhancing transplant safety: A new era in the microbiologic evaluation of organ donors Am J Transplant 2007 7 : 2652 2654.
12. Hardy WD Jr. General principles of retrovirus immunodetection tests. J Am Vet Med Assoc 1991 199 : 1282 1287.
13. Kleinman SH, Busch MP. Assessing the impact of HBV NAT on window period reduction and residual risk. J Clin Virol 2006 36 (Suppl 1 S23 29.
14. Kleinman SH, Kuhns MC, Todd DS et al. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: Implications for transfusion transmission and donor screening. Transfusion 2003 43 : 696 704.
15. Yao F, Seed C, Farrugia A et al. The risk of HIV, HBV, HCV and HTLV infection among musculoskeletal tissue donors in Australia. Am J Transplant 2007 7 : 2723 2726.
16. Grady D. Four transplant recipients contract HIV. 2007. Available from : http://www.nytimes.com/2007/11/13/health/13cnd-organ.html?em&ex= 1195189200&en=4aa09291f000fe7b&ei=5087%0A. Accessed June 18, 2008.
17. Halpern SD, Shaked A, Hasz RD, Caplan AL. Informing candidates for solid-organ transplantation about donor risk factors. N Engl J Med 2008 358 : 2832 2837.
18. Kucirka LM AC, Namuyinga R, Hanrahan C, Montgomery RA, Segev DL. Viral nucleic acid testing (NAT) and disposition of high-risk donor organs. Am J Transplant 2008 in press.
19. UNOS. 2007 UNOS National Data Report. Available at : http://www.unos.org. Accessed September 12, 2008.